You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IIB

Showing 1 - 25 of 2,450
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

Not yet recruiting
  • Meningioma
  • Vandœuvre-lès-Nancy, Grand Est, France
  • +1 more
Nov 8, 2023

NMO Spectrum Disorder, Spasticity, Muscle Trial in Boston (Nabiximols, Placebo)

Not yet recruiting
  • NMO Spectrum Disorder
  • Spasticity, Muscle
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 2, 2023

Efficacy, Safety, Pharmacokinetics Trial in Jilin (Hepenofovir Fumarate Tablets)

Recruiting
  • Efficacy
  • +2 more
  • Hepenofovir Fumarate Tablets
  • Jilin, Changchun, China
    The First Hospital of Jilin University
Nov 2, 2023

NSCLC Trial (Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Jun 22, 2023

Age-related Cognitive Decline Trial in Iowa City, Dallas (Computerized Plasticity-Based Adaptive Cognitive Training)

Not yet recruiting
  • Age-related Cognitive Decline
  • Computerized Plasticity-Based Adaptive Cognitive Training
  • Iowa City, Iowa
  • +1 more
Oct 28, 2022

Diabetic Nephropathies Trial in Daegu (CU01-1001, Placebo)

Recruiting
  • Diabetic Nephropathies
  • Daegu, Korea, Republic of
    Yeongnam University Medical Center
Feb 6, 2023

Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Recruiting
  • Non Small Cell Lung Cancer
  • anti-PD-1 or anti-PD-L1
  • +2 more
  • Shanghai, China
    Oncology Department, Shanghai Chest Hospital
Jul 26, 2022

Transplant Complication Trial (Pooled allogeneic fecal microbiotherapy, Placebo)

Not yet recruiting
  • Transplant Complication
  • Pooled allogeneic fecal microbiotherapy
  • Placebo
  • (no location specified)
Feb 27, 2023

Adult Acute Myeloid Leukemia Trial (mocravimod)

Not yet recruiting
  • Adult Acute Myeloid Leukemia
  • (no location specified)
Jun 27, 2022

Leiomyosarcoma Trial in Los Angeles (Lurbinectedin, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Los Angeles, California
    Sarcoma Oncology Center
Oct 16, 2023

Neonatal Seizure, Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy Trial in San Diego (Levetiracetam Injection,

Not yet recruiting
  • Neonatal Seizure
  • +3 more
  • Levetiracetam Injection
  • Phenobarbital Sodium Injection
  • San Diego, California
    University of California, San Diego
Nov 6, 2022

Cervical Cancer, Stage IIB Trial in Mexico City (Placebo dairy beverage)

Completed
  • Cervical Cancer, Stage IIB
  • Placebo dairy beverage
  • Mexico City, Tlalpan, Mexico
    National Cancer Institute of Mexico
Feb 16, 2023

COVID-19 Vaccine Trial in Ciudad autónoma de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aires

Active, not recruiting
  • COVID-19 Vaccine
  • Ad5-nCov
  • Ciudad autónoma de Buenos Aires, Buenos Aires, Argentina
  • +2 more
Sep 28, 2022

Intermittent Claudication, Peripheral Arterial Disease Trial in Matsuyama, Fukuoka, Osaka (DVC1-0101)

Active, not recruiting
  • Intermittent Claudication
  • Peripheral Arterial Disease
  • Matsuyama, Ehime, Japan
  • +3 more
Aug 16, 2022

ARDS Trial in Tel-Aviv (EXO-CD24, Placebo)

Recruiting
  • ARDS
  • Tel-Aviv, Israel
    Tel-Aviv Sourasky Medical Center
Jul 7, 2023

Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

Active, not recruiting
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • +19 more
  • Gilbert, Arizona
  • +4 more
Dec 6, 2022

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Amyotrophic Lateral Sclerosis, ALS Trial in Tel Aviv (PrimeC, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • ALS
  • Loma Linda, California
  • +2 more
Nov 23, 2022

Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

Not yet recruiting
  • Chronic Hepatitis Delta Virus Infection
  • HH-003(20mg/kg)
  • +2 more
  • (no location specified)
May 7, 2023

Breast Cancer Female, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial in Kampala

Completed
  • Breast Cancer Female
  • +11 more
  • Kampala, Uganda
  • +1 more
Jun 7, 2022

Urinary System Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Urinary System Tumor
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Mar 26, 2023

NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

Recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • Toripalimab
  • +3 more
  • Guanzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Apr 4, 2023

Ocular Inflammation, Cataract Trial in Campinas (SATURNO II association, Vigadexa®)

Completed
  • Ocular Inflammation
  • Cataract
  • Campinas, São Paulo, Brazil
    Allegisa
Mar 4, 2022

Cervical Cancer, Stage IIB Trial (Curcumin, Placebo oral tablet)

Withdrawn
  • Cervical Cancer, Stage IIB
  • (no location specified)
Dec 5, 2022

Metastatic Colorectal Cancer Trial in Bronx, Houston (AlloStim)

Recruiting
  • Metastatic Colorectal Cancer
  • AlloStim
  • Florham Park, New Jersey
  • +1 more
Aug 30, 2022